Register or Sign in
to unlock feature

you are not authorized to read this article.

Login or register your account to get full access to the tableting technology platform.

Login Register
Please verify your account
Please confirm your email address to validate your registration. Follow the link on email received to verify your email adress.
Re-send verification email
Please complete your registration
You're logged in but you didn't complete your registration.
Complete my registration
Exclusive content

You are not authorized to read this article.

mystylone subscription is required to view this content.

Login Register
Close search
  • Resources
  • Products & Services
    • Compaction Simulators
    • R&D / Process Support
  • Events
  • About
  • Contact Us
  • Sign in
Resources
  1. Home /
  2. Resources /
  3. Newsfeeds /
  4. Building the Pharma 4.0 foundation
NEWSFEEDS

Building the Pharma 4.0 foundation

January 23, 2025
Remove from favorites
Add to favorites

The article highlights the importance of deploying a comprehensive asset management strategy for pharmaceutical companies to fully benefit from Industry 4.0 technologies. Industry 4.0, also known as Pharma 4.0 in the pharmaceutical sector, leverages technologies like IoT, AI, machine learning, and AR/VR to improve efficiency, reduce costs, and enhance quality. However, many companies struggle to achieve a return on investment due to inadequate foundational strategies and competencies.

Key points include:

- Pharma 4.0 Foundations: The International Society for Pharmaceutical Engineering’s (ISPE) Pharma 4.0 Special Interest Group emphasizes the need for a structured approach to align digital transformation efforts with regulatory and operational requirements. This includes data integrity, organizational alignment, and cultural readiness.

- Asset Management Strategy: Effective implementation of Pharma 4.0 requires robust asset management guided by the ISO 55000 series. This standard outlines how to manage assets throughout their lifecycle, aligning technological solutions with organizational goals and stakeholder requirements.

- Critical Asset Focus: Companies must prioritize their most critical assets through failure analysis methods, such as Failure Modes and Effects Analysis (FMEA), and implement strategies to mitigate risks proactively.

- People and Competencies: Human resource readiness is essential for digital transformation. The article underscores the need for training, competency development, and change management to ensure employees adapt to new technologies and processes.

- Organizational Change Management (OCM): Cultural shifts and employee engagement are critical for the success of Industry 4.0 initiatives. Prosci’s OCM framework highlights the importance of structured processes to address the "people side" of change.

The article concludes that there is no universal solution to Pharma 4.0 adoption. Instead, companies must adopt proven methods to prioritize capabilities, develop competencies, and align strategic goals with technological advancements, ensuring sustainable and effective digital transformation.

Read more
standard tablets on blue background
Contributor(s):
Share Copied!
Comments

No comments posted yet.

Add a comment

Articles you may like

Impact of unloading kinematics on the occurrence of capping during the production of pharmaceutical tablets

Impact of unloading kinematics on the occurrence of capping during the production of pharmaceutical tablets

first_published_at:June 10, 2022, midnight / date_published:June 10, 2022
Papers - 10/06/2022 - by J. Meynard, F. Amado-Becker, P. Tchoreloff, V. Mazel
Capping, a common defect in pharmaceutical tablet manufacturing, has been associated with a decrease in the unloading speed during the manufacturing cycle, as indicated by several studies. Building on this …

no-image

Multivariate data analysis for tableting perofrmance improvement at industrial scale.

first_published_at:Sept. 15, 2023, midnight / date_published:Sept. 15, 2023
Papers - 15/09/2023 - by Rita Mathe, Tibor Casian, Adriana Marina, Damaris Daiana Marusca, Ioan Tomuta
This study aimed to explore the granule properties and processing conditions leading to capping and lamination phenomena in a high drug load, wet granulated, film-coated product. A comprehensive analysis was …

illustration Exploring Best-Practice Manufacturing Strategies for Highly Potent Oral Solid Dosage Forms

Exploring best-practice manufacturing strategies for highly potent oral solid dosage forms

first_published_at:Nov. 23, 2023, 2:43 p.m. / date_published:None
Newsfeeds - 23/11/2023 -
Exploring key points for manufacturing Highly Potent Oral Solid Dosage Forms:*Challenges of Highly Potent Oral Solid Dose (HPOSD) Manufacturing:The increasing development and market presence of highly potent oral solid dose …

More

Related products

Take_off_sensor

Linear Ejection Device

MEDELPHARM
Introducing the linear ejection device, a versatile accessory designed to seamlessly integrate with the STYL'One …
Accessory_Evo_TabInTab_16

Tab-in-Tab Device

MEDELPHARM
Tab-in-tab technology showcases multiple advantages including enhanced drug stability, modified release profiles, taste masking, combination …
Accessory_Evo_gravity_feeder_3

Gravity Feeder - STYL'One Evo

MEDELPHARM
The primary function of compaction simulators is to provide reliable data from which information can …
Tapping Feeder - STYL'One Evo 4

Tapping Feeder - STYL'One Evo

MEDELPHARM
The primary function of compaction simulators is to provide reliable data from which information can …
Paddle Force Feeder - STYL'One Nano 1

Paddle Force Feeder - STYL'One Nano

MEDELPHARM
The primary function of compaction simulators is to provide reliable data from which information can …
illustration STYL'One Mist manual lubrication

Manual External Lubrication

MEDELPHARM
In development, external lubrication enables the characterization of the compaction behavior of pure APIs or …
Evolution_resize

STYL'One Evo

MEDELPHARM
The STYL’One Evolution pushes further the limit of simulation with high speed rotary presses or …
0.STYLOne_Nano_y66g4Pc_resize

STYL'One Nano

MEDELPHARM
Single-punch presses are ideal at formulation stage: easy to operate, easy to clean and for …
STYLOne_EVO_OEB3_sans_fond_mod_resize

STYL'One Evo DryCon®

MEDELPHARM
The STYL’One Evo is designed to work under negative pressure and as such, the standard …
STYLONE_EVO_OEB5_transparent_apxkk5N_resize

STYL'One Evo WipCon®

MEDELPHARM
The STYL’One Evo is designed to work under negative pressure and as such, the standard …
laptop laboratory gloves

Looking for additional information?

Let us help you

Contact our experts

GENERAL

  • Terms of service
  • Privacy Policy
  • Cookie Policy
  • About
  • Contact us

Account

  • Login

Follow us on

© 2025 Medelpharm